Related Experiment Video
Updated: Sep 3, 2026

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
Published on: May 11, 2015
Circular RNAs regulate the progression of pulmonary hypertension through distinct roles and mechanisms
Gui-Feng Lu1, Yao Guo2, Fei Geng3
1Department of Cardiovascular Medicine, the First Affiliated Hospital of Shantou University Medical College, Shantou, China; Department of Molecular Medicine, Shantou University Medical College, Shantou, China.
Abstract:
Pulmonary hypertension (PH) is a progressive, life-threatening vascular disorder driven by pulmonary vascular remodeling and right ventricular dysfunction. Circular RNAs have emerged as key regulators of PH pathogenesis. In this review, we critically evaluate circular RNA expression profiles in clinical and experimental PH samples and synthesize their functional roles into 5 core pathogenic modules. The first 4 modules focus on pulmonary vascular cells (smooth muscle cells and endothelial cells): (1) transforming growth factor-β/bone morphogenetic protein receptor type-2 and phosphoinositide 3-kinase signaling; (2) noncanonical cell death (ferroptosis, pyroptosis, and autophagy); (3) epitranscriptomic, chromatin, and posttranslational regulation; and (4) metabolic reprogramming. The fifth module addresses (5) right ventricular remodeling. We also discuss their biomarker potential, therapeutic strategies, delivery challenges, and limitations. Collectively, this modular framework reveals that numerous dysregulated circular RNAs converge on limited shared pathways, underscoring their diagnostic and therapeutic potential in PH. SIGNIFICANCE STATEMENT: This review offers insights into circular RNA functions across key pathological processes of pulmonary hypertension, with the overall goal of identifying shared molecular pathways and developing them as novel biomarkers and therapeutic targets for this intractable vascular disorder.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Regulation of Angiogenesis and Blood Supply
Respiratory Syncytial Virus Disease
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
